A large and highly significant difference in EBNA-1 IgM/IgG/IgA levels between RA patients and HCs and between RA patients and SLE patients (P < 0.0001 for all 3 antibody isotypes) was observed. This evidence concerns the gene CD79A and systemic lupus erythematosus.